Back
Top 5%
15.3%
Top 2%
12.4%
#1
10.5%
Top 2%
8.2%
Top 2%
6.7%
Top 70%
6.7%
Top 54%
5.3%
Top 5%
2.9%
Top 5%
2.0%
Top 3%
2.0%
Top 3%
2.0%
Top 4%
1.6%
Top 3%
1.6%
Top 16%
1.4%
Top 3%
1.4%
Top 0.8%
1.2%
Top 5%
1.0%
Top 9%
0.7%
Top 13%
0.7%
Top 6%
0.7%
Top 6%
0.7%
Top 4%
0.7%
Top 16%
0.7%
Top 8%
0.5%
Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer
2026-02-23
oncology
Title + abstract only
View on medRxiv
Show abstract
PurposeCirculating tumor DNA (ctDNA) analyses are informative as an early indicator of immunotherapy response in advanced non-small cell lung cancer (NSCLC); however, the clinical value of ctDNA molecular response requires further validation. Patients and MethodsAs part of a prospective clinical protocol (NCT05995821), we conducted targeted error-correction sequencing of ctDNA (n=328) and matched WBC DNA (n=109) from 109 patients with metastatic NSCLC who received anti-PD-(L)1 either as monothe...
Predicted journal destinations
1
Nature Communications
483 training papers
2
Cancers
57 training papers
3
Clinical Cancer Research
22 training papers
4
eLife
262 training papers
5
Frontiers in Oncology
34 training papers
6
PLOS ONE
1737 training papers
7
Scientific Reports
701 training papers
8
Frontiers in Immunology
140 training papers
9
Proceedings of the National Academy of Sciences
100 training papers
10
British Journal of Cancer
22 training papers
11
Cancer Medicine
17 training papers
12
iScience
74 training papers
13
BMC Cancer
21 training papers
14
JAMA Network Open
125 training papers
15
Journal of Clinical Investigation
50 training papers
16
Cell Reports
25 training papers
17
Cell Reports Medicine
49 training papers
18
Nature
58 training papers
19
PLOS Computational Biology
141 training papers
20
International Journal of Molecular Sciences
39 training papers
21
Communications Medicine
63 training papers
22
Communications Biology
36 training papers
23
Nature Medicine
88 training papers
24
Diagnostics
36 training papers